In brief: A few months after acquiring Arduino, Qualcomm is introducing its first product designed to combine its processor technology with the "maker" ethos of the Italian company. Unsurprisingly, ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

Bristol Myers Squibb (NYSE: BMY; BMS) delivered some good news to investors in reporting fourth-quarter and full-year 2025 results on Thursday. The pharma giant beat analyst consensus forecasts by ...

Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...

Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...

Nearly 4,500 Tesla Model 3 and Model Y owners in South Korea have complained about battery malfunctions that prevent charging. The problem, which primarily affects 2021 models, has drawn the scrutiny ...

In a deal that surprised some industry observers, chipmaker Qualcomm has agreed to buy Arduino, which is best known for supplying microcontrollers to the DIY community. The acquisition, whose terms ...

Qualcomm's acquisition gives it access to millions of developers in the Arduino ecosystem while also supporting its platform strategy for embedded devices, which now extends across hardware, software, ...

Qualcomm announced Tuesday it will acquire Arduino for undisclosed terms. The chipmaker said the Italy-based company would become an independent subsidiary of Qualcomm. In this article Qualcomm wants ...

Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

Sigvotatug vedotin (SV), an investigational integrin beta-6 (IB6)–directed antibody‒drug conjugate (ADC), and pembrolizumab combination therapy: Initial results from an ongoing phase 1 study ...